385 related articles for article (PubMed ID: 27468945)
1. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
[TBL] [Abstract][Full Text] [Related]
2. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
[TBL] [Abstract][Full Text] [Related]
3. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
[TBL] [Abstract][Full Text] [Related]
4. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
Braune SA; Wichmann D; von Heinz MC; Nierhaus A; Becker H; Meyer TN; Meyer GP; Müller-Schulz M; Fricke J; de Weerth A; Hoepker WW; Fiehler J; Magnus T; Gerloff C; Panzer U; Stahl RA; Wegscheider K; Kluge S
Crit Care Med; 2013 Jul; 41(7):1702-10. PubMed ID: 23660733
[TBL] [Abstract][Full Text] [Related]
6. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome.
Chokoshvili O; Lomashvili K; Malakmadze N; Geleishvil M; Brant J; Imnadze P; Chitadze N; Tevzadze L; Chanturia G; Tevdoradze T; Tsertsvadze T; Talkington D; Mody RK; Strockbine N; Gerber RA; Maes E; Rush T
J Epidemiol Glob Health; 2014 Dec; 4(4):249-59. PubMed ID: 25455642
[TBL] [Abstract][Full Text] [Related]
7. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome in children.
Talarico V; Aloe M; Monzani A; Miniero R; Bona G
Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
[TBL] [Abstract][Full Text] [Related]
9. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Peco-Antić A
Srp Arh Celok Lek; 2016; 144(11-12):664-9. PubMed ID: 29659236
[TBL] [Abstract][Full Text] [Related]
10. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.
Doulgere J; Otto B; Nassour M; Wolters-Eisfeld G; Rohde H; Magnus T; Wagener C; Streichert T
BMJ Open; 2015 Mar; 5(3):e005659. PubMed ID: 25757942
[TBL] [Abstract][Full Text] [Related]
11. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
[TBL] [Abstract][Full Text] [Related]
12. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
[TBL] [Abstract][Full Text] [Related]
13. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
[TBL] [Abstract][Full Text] [Related]
14. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
15. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.
King LA; Nogareda F; Weill FX; Mariani-Kurkdjian P; Loukiadis E; Gault G; Jourdan-DaSilva N; Bingen E; Macé M; Thevenot D; Ong N; Castor C; Noël H; Van Cauteren D; Charron M; Vaillant V; Aldabe B; Goulet V; Delmas G; Couturier E; Le Strat Y; Combe C; Delmas Y; Terrier F; Vendrely B; Rolland P; de Valk H
Clin Infect Dis; 2012 Jun; 54(11):1588-94. PubMed ID: 22460976
[TBL] [Abstract][Full Text] [Related]
17. Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.
Delmas Y; Vendrely B; Clouzeau B; Bachir H; Bui HN; Lacraz A; Hélou S; Bordes C; Reffet A; Llanas B; Skopinski S; Rolland P; Gruson D; Combe C
Nephrol Dial Transplant; 2014 Mar; 29(3):565-72. PubMed ID: 24293658
[TBL] [Abstract][Full Text] [Related]
18. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.
McKee RS; Schnadower D; Tarr PI; Xie J; Finkelstein Y; Desai N; Lane RD; Bergmann KR; Kaplan RL; Hariharan S; Cruz AT; Cohen DM; Dixon A; Ramgopal S; Rominger A; Powell EC; Kilgar J; Michelson KA; Beer D; Bitzan M; Pruitt CM; Yen K; Meckler GD; Plint AC; Bradin S; Abramo TJ; Gouin S; Kam AJ; Schuh A; Balamuth F; Hunley TE; Kanegaye JT; Jones NE; Avva U; Porter R; Fein DM; Louie JP; Freedman SB;
Clin Infect Dis; 2020 Apr; 70(8):1643-1651. PubMed ID: 31125419
[TBL] [Abstract][Full Text] [Related]
19. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.
Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S
Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918
[TBL] [Abstract][Full Text] [Related]
20. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.
Joseph A; Cointe A; Mariani Kurkdjian P; Rafat C; Hertig A
Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31973203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
